Viewing Study NCT03427866


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-02-05 @ 9:35 PM
Study NCT ID: NCT03427866
Status: COMPLETED
Last Update Posted: 2025-07-29
First Post: 2018-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module